Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation.

Delivery is one of the most critical obstacles confronting nanoparticle use in cancer diagnosis and therapy. For most oncological applications, nanoparticles must extravasate in order to reach tumor cells and perform their designated task. However, little understanding exists regarding the effect of nanoparticle shape on extravasation. Herein we use real-time intravital microscopic imaging to meticulously examine how two different nanoparticles behave across three different murine tumor models. The study quantitatively demonstrates that high-aspect ratio single-walled carbon nanotubes (SWNTs) display extravasational behavior surprisingly different from, and counterintuitive to, spherical nanoparticles although the nanoparticles have similar surface coatings, area, and charge. This work quantitatively indicates that nanoscale extravasational competence is highly dependent on nanoparticle geometry and is heterogeneous.

[1]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[2]  Joseph M DeSimone,et al.  Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[3]  Monika Sramkova,et al.  Intravital microscopy: a novel tool to study cell biology in living animals , 2010, Histochemistry and Cell Biology.

[4]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[5]  D. McDonald,et al.  Significance of blood vessel leakiness in cancer. , 2002, Cancer research.

[6]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[7]  H. Dai,et al.  Preparation of carbon nanotube bioconjugates for biomedical applications , 2009, Nature Protocols.

[8]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[9]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Y. Durocher,et al.  Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling , 2008, Oncogene.

[11]  N. Melosh,et al.  Nanostraws for direct fluidic intracellular access. , 2012, Nano letters.

[12]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[13]  Zhen Cheng,et al.  In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. , 2010, Bioconjugate chemistry.

[14]  R K Jain,et al.  Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. , 1999, Biophysical journal.

[15]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[16]  M. Yokoyama,et al.  Vital microscopic analysis of polymeric micelle extravasation from tumor vessels: macromolecular delivery according to tumor vascular growth stage. , 2010, Journal of pharmaceutical sciences.

[17]  M. Dewhirst,et al.  Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. , 2000, Cancer research.

[18]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[19]  Michael M. Schmidt,et al.  A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.

[20]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Robert Sinclair,et al.  Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. , 2008, Nano letters.

[22]  Xiaohu Gao,et al.  Multifunctional Quantum Dots for Personalized Medicine. , 2009, Nano today.

[23]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Gambhir,et al.  Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. , 2008, Nano letters.

[25]  S. Wise.  Nanocarriers as an emerging platform for cancer therapy , 2007 .

[26]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[27]  S. Gambhir,et al.  Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. , 2010, Small.

[28]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[29]  Dai Fukumura,et al.  Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.

[30]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[32]  Vladimir P Torchilin,et al.  Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.

[33]  H. Maeda,et al.  Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[34]  G. Lapin,et al.  Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. , 1999, Microvascular research.

[35]  Vladimir R Muzykantov,et al.  Polymeric carriers: role of geometry in drug delivery. , 2008, Expert opinion on drug delivery.

[36]  Ralph Weissleder,et al.  Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. , 2009, Neoplasia.

[37]  Diffusion of polymers near a fluid-fluid interface or a wall , 1976 .

[38]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[39]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[40]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[41]  Colin M. Wilson,et al.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors , 2009, Journal of Translational Medicine.

[42]  Betty Y. S. Kim,et al.  Current concepts: Nanomedicine , 2010 .